Proceedings of the 1st biannual bridging the gaps in lung cancer conference. Read more about Proceedings of the 1st biannual bridging the gaps in lung cancer conference.
Immune-related encephalitis after immune checkpoint inhibitor therapy. Read more about Immune-related encephalitis after immune checkpoint inhibitor therapy.
Synchronous or metachronous breast and colorectal cancers in younger-than-average-age patients: a case series. Read more about Synchronous or metachronous breast and colorectal cancers in younger-than-average-age patients: a case series.
HER2 overexpression in urothelial carcinoma with GATA3 and PPARG copy number gains. Read more about HER2 overexpression in urothelial carcinoma with GATA3 and PPARG copy number gains.
Evaluation of Culture Conducive to Academic Success by Gender at a Comprehensive Cancer Center. Read more about Evaluation of Culture Conducive to Academic Success by Gender at a Comprehensive Cancer Center.
The Landscape of US and Global Rare Tumor Research Programs: A Systematic Review. Read more about The Landscape of US and Global Rare Tumor Research Programs: A Systematic Review.
Left Ventricular Ejection Fraction in Patients With Ovarian Cancer Treated With Avelumab, Pegylated Liposomal Doxorubicin, or Both. Read more about Left Ventricular Ejection Fraction in Patients With Ovarian Cancer Treated With Avelumab, Pegylated Liposomal Doxorubicin, or Both.
Molecular Characterization of HER2-Low Invasive Breast Carcinoma by Quantitative RT-PCR Using Oncotype DX Assay. Read more about Molecular Characterization of HER2-Low Invasive Breast Carcinoma by Quantitative RT-PCR Using Oncotype DX Assay.
Evaluating Survival After Hospitalization Due to Immune-Related Adverse Events From Checkpoint Inhibitors. Read more about Evaluating Survival After Hospitalization Due to Immune-Related Adverse Events From Checkpoint Inhibitors.
Atezolizumab Plus PEGPH20 Versus Chemotherapy in Advanced Pancreatic Ductal Adenocarcinoma and Gastric Cancer: MORPHEUS Phase Ib/II Umbrella Randomized Study Platform. Read more about Atezolizumab Plus PEGPH20 Versus Chemotherapy in Advanced Pancreatic Ductal Adenocarcinoma and Gastric Cancer: MORPHEUS Phase Ib/II Umbrella Randomized Study Platform.
